Table 2 |
||||
|
Laboratory markers of malaria disease severity |
||||
| n (%) |
||||
|
|
||||
| Pre |
Post |
PR* [95% CI] |
chi-squared p-value |
|
|
|
||||
| Slide-positive (N = 386) |
205 (80.4) |
63 (48.1) |
1.67 [1.39–2.02] |
<0.0001 |
| Suspected malaria, no slide results available (N = 51) |
32 (11.1) |
19 (12.7) |
0.88 [0.52–1.50] |
0.64 |
| High parasitaemia (N = 268) |
116 (56.6) |
22 (34.9) |
1.62** [1.11–2.38] |
0.004 |
| Severe anemia, slide-positive admissions (N = 161) |
21 (18.9) |
4 (8.0) |
2.47** [0.84–7.24] |
0.08 |
| Severe anemia, all hospitalizations (N = 307) |
23 (15.3) |
6 (3.8) |
3.85** [1.60–9.25] |
0.001 |
| No hemoglobin result (N = 244) |
172 (53.4) |
72 (31.4) |
1.70 [1.37–2.11] |
<0.0001 |
|
|
||||
|
Results for laboratory-definable markers of disease severity: admission haemoglobin and admission peripheral parasitaemia are shown. For parasitaemia, percents are recorded as proportion of pre-intervention, post-intervention, or total admissions for malaria for which a slide result was available. For low vs. high (3+-4+) parasitaemia, percents are recorded as proportion of total slide-positive malaria admissions. For missing data, percentages are recorded as proportion of total malaria admissions for which slide results were unavailable. Severe anemia is defined as ≤ 5 g/dl. * Prevalence ratio comparing the proportion in the pre-intervention period to the proportion in the post-intervention period. ** adjusted for age using three categories (<1 year; 1–5 years; > 5 years) |
||||
|
Sievers et al. Malaria Journal 2008 7:167 doi:10.1186/1475-2875-7-167 |
||||
